Hilary Mcelwaine-Johnn

Chief Medical Officer at EXACT Therapeutics

A highly experienced Chief Medical Officer, graduate of Imperial College and St Mary’s Hospital Medical School, London, Member of the Royal College of Physicians and Faculty of Pharmaceutical Medicine. 25+ years of drug development experience including PowderMed, PsiOxus Therapeutics and Karus Therapeutics.


Org chart


Teams


Offices

This person is not in any offices


EXACT Therapeutics

1 followers

EXACT Therapeutics is a clinical stage Norwegian biotech company developing a technology platform for targeted therapeutic enhancement – Acoustic Cluster Therapy (ACT®). ACT®sonoporation is a unique approach to ultrasound-mediated, targeted drug enhancement – with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.


Industries

Headquarters

Oslo, Norway

Employees

11-50

Links